Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hormone replacement therapy and venous thromboembolism].

N Trillot1, S Susen, B Jude

  • 1Laboratoire d'hématologie, hôpital cardiologique, CHRU de Lille, 2, avenue Oscar-Lambret, 59037 Lille, France. n-trillot@chru-lille.fr

Gynecologie, Obstetrique & Fertilite
|September 24, 2004
PubMed
Summary

Hormone replacement therapy (HRT) increases venous thromboembolism risk in women. Careful evaluation of individual risk factors is crucial before prescribing HRT, especially for those with a history of blood clots.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coagulation standards in healthy newborns and infants.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2020
Same author

Von Willebrand disease: Clinical conundrums.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.

European journal of neurology·2018
Same author

French lyophilized plasma versus fresh frozen plasma for the initial management of trauma-induced coagulopathy: a randomized open-label trial.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Rapid negative inotropic effect induced by TNF-α in rat heart perfused related to PKC activation.

Cytokine·2017
Same author

Compliance with evidence-based clinical management guidelines in bleeding trauma patients.

British journal of anaesthesia·2016

Area of Science:

  • Genetics and Thrombosis
  • Hormone Replacement Therapy (HRT) and Cardiovascular Health

Context:

  • Venous thromboembolism (VTE) is a complex disease influenced by multiple genes and factors.
  • Identified genetic risks include deficiencies in antithrombin, protein C, protein S, and mutations in factor V and factor II genes.
  • Previous studies link hormone replacement therapy (HRT) to a 2-3 fold increase in VTE events.

Purpose:

  • To highlight the association between HRT and increased VTE risk.
  • To emphasize the importance of assessing individual clinical risk factors before HRT prescription.
  • To guide clinical decisions regarding HRT use in women with thrombophilia or a history of VTE.

Summary:

  • HRT use is associated with a significantly increased risk of venous thromboembolism.

Related Experiment Videos

  • Women with a history of thromboembolic events should avoid HRT.
  • Caution is advised for women with familial thrombophilia; transdermal HRT may offer a lower risk, pending further research.

    • Impact:

    • Informs clinical practice on the safe prescription of HRT.
    • Promotes personalized risk-benefit assessment for women considering HRT.
    • Highlights the need for ongoing research into safer HRT alternatives for at-risk populations.